Julian Bailes

Chief Tech/Sci/R&D Officer at BLUE WATER VENTURES INTERNATIONAL, INC.

Commercial Services

Health Technology

Profile

Julian Bailes currently works at Psycheceutical Bioscience, Inc., as Director & Chief Medical Officer and Psycheceutical, Inc., as Director & Chief Medical Officer from 2023.

Julian Bailes active positions

Companies	Position	Start
BLUE WATER VENTURES INTERNATIONAL, INC.	Chief Tech/Sci/R&D Officer	-
Psycheceutical, Inc. Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021.	Chief Tech/Sci/R&D Officer	10/01/2023

All active positions of Julian Bailes

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Julian Bailes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BLUE WATER VENTURES INTERNATIONAL, INC.	Commercial Services

Private companies	1
Psycheceutical, Inc. Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021.	Health Technology